The Yahoo Finance's Dave Briggs and Seana Smith discuss Hims & Hers' latest earnings release and the movement in the company's stock.
#Hims&Hers Hims & Hers CFO Yemi Okupe joins Yahoo Finance Live anchors Brad Smith and Julie Hyman to discuss company earnings, competition in the wellness industry, and the outlook for growth opportun
Hims & Hers Health, Inc. (HIMS) delivered earnings and revenue surprises of 28.57% and 4.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st
Hims & Hers Health, Inc. (NYSE:HIMS ) Q4 2022 Earnings Conference Call February 27, 2023 5:00 PM ET Company Participants Alice Lopatto - Vice President of Investor Relations Andrew Dudum - Chief Execu
Yahoo Finance anchor Seana Smith takes a look at some of the biggest movers in after-hours trading.
Shares of Hims & Hers Health Inc. HIMS, -1.23% rose more than 9% in the after-hours session Monday after the telehealth company reported narrower fourth-quarter results and revenue that was above expe
Investors take an analyst's very positive change in sentiment to heart.

Hims & Hers: Profitability Pulled Forward

03:29pm, Wednesday, 25'th Jan 2023
Hims & Hers pulled forward its profitability. HIMS is now expected to be EBITDA profitable in Q4 2022, months ahead of schedule.
Telehealth is gaining strong adoption momentum amongst younger generations. HIMS has a very attractive business model.
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, including Alphabet & Intuitive Surgical

Hims & Hers Health: The Ultimate Pick For 2023

03:52pm, Friday, 23'rd Dec 2022
Hims & Hers Health is a telehealth company which solves two major issues for patients in modern healthcare: it provides easier access to physicians and lower cost treatments. Hims is growing at a blis
Hims & Hers Health, Inc. blew their original 2022 financial projections out of the water. The company is a growth investor's dream: large TAM, predictable subscription revenue, tech-company margins, a
Hims & Hers Health has demonstrated resilient margins and accelerating growth in 2022 with no signs of slowing down, supported by rapidly expanding telehealth market and good brand recognition. The co

5 Stocks That Could Double Your Money in 2023

09:53am, Friday, 02'nd Dec 2022
100% gains in this market? It's not as crazy as it sounds.
Hims & Hers is a small-cap stock that is on track to nearly double its revenue this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE